Abstract:®‐hydroxybutyrate has been used to treat epilepsy and plays a neuro‐protective role in models of neurodegenerative diseases. Ketogenic diets are under evaluation as adjunctive treatment for patients with brain tumors and other malignancies. These lines of evidence suggest a regulatory role for ketone bodies beyond serving as an energy source. However, the mechanisms underlying these physiological and pharmacological effects of ketone bodies remain largely unknown. We had previously identified lysine ®‐hydroxybutyrylation (Kbhb) as a new type of histone modification. We showed that histone Kbhb is dramatically induced in livers from mice subjected to prolonged fasting or streptozotocin‐induced diabetic ketoacidosis. By ChIP‐seq and RNA‐seq analysis, we demonstrated that histone Kbhb is a mark enriched in active gene promoters, and that the increased H3K9bhb levels during starvation are associated with genes up‐regulated in starvation‐responsive metabolic pathways. We now have new data to show that p300 can catalyze histone Kbhb both in vitro and in cultured cell lines. Using in vitro transcription assay with recombinant chromatin, we demonstrate that p300‐catalyzed histone Kbhb can activate transcription directly. All together, our study suggest histone Kbhb as a new epigenetic regulatory mark that couples metabolism to gene expression, offering a new avenue to study chromatin regulation and the diverse functions of ®‐hydroxybutyrate in the context of important human pathophysiological states, including diabetes, epilepsy, and neoplasia. Support or Funding Information The work was supported by: NIH DK089098, P01 DK057751, CT DPH 2014‐0139 and Ellison Medical Foundation to X.Y.; NIH DK71900 and the Starr Foundation Tri‐Institutional Stem Cell Initiative (2014‐021) to R.G.R.; NIH R01GM101171 and R21CA177925 to D.L.; NIH GM59507 to H. Z.; NIH R01AG030593 and R01AG023166 to S.D.P.; National Natural Science Foundation of China (81125023) and Shanghai Commission of Science and Technology (14431902800) to J.L and J.L.; National Basic Research Program of China (973 Program) (No. 2014CBA02004) and the Shanghai Municipal Science and Technology Commission (No. 15410723100) to M.T.

Metabolic Diseases Downregulate the Majority of Histone Modification Enzymes, Making a Few Upregulated Enzymes Novel Therapeutic Targets--"Sand out and Gold Stays".

The Expressions of 164 Histone Modification Enzymes in Seven Groups Are Modulated in Respond to Pathogenic Processes of Metabolic Diseases, Tumors and Regulatory T Cell Differentiation

Demethylation of the Protein Phosphatase PP2A Promotes Demethylation of Histones to Enable Their Function As a Methyl Group Sink.

Epigenetic Enzymes Are Replaced in Atherogenesis and Regulatory T Cell Conversion by Groups of Upregulated Enzymes

Specific regulation of epigenome landscape by metabolic enzymes and metabolites

Histone Deacetylases in Modulating Cardiac Disease and Their Clinical Translational and Therapeutic Implications

Metabolic Substrates, Histone Modifications, and Heart Failure.

Histone acylation marks respond to metabolic perturbations and enable cellular adaptation

Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases

Metabolic enzymes function as epigenetic modulators: A Trojan Horse for chromatin regulation and gene expression

Function and Mechanism of Novel Histone Posttranslational Modifications in Health and Disease

Role of Histone Deacetylases in Skeletal Muscle Physiology and Systemic Energy Homeostasis: Implications for Metabolic Diseases and Therapy

Metabolic Regulation of Gene Expression by Histone Lysine β‐hydroxybutyrylation

Histone Deacetylases in Metabolism: The Known and the Unexplored

Post‐translational modifications of histones: Mechanisms, biological functions, and therapeutic targets

Metabolic regulation of gene expression through histone acylations

Regulation of Chromatin and Gene Expression by Metabolic Enzymes and Metabolites

Role of Histone Acetylation Modification in Posttranscriptional Gene Expression

Metabolic regulation of gene expression by histone lactylation

Acetylation in pathogenesis: Revealing emerging mechanisms and therapeutic prospects

Writing, erasing and reading histone lysine methylations